Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Atherosclerosis and endocrine disorders]

S Akazawa1, H Yamasaki, Y Yamaguchi

  • 1First Department of Internal Medicine, Nagasaki University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recent advances in basic and applied science for the control of taeniasis/cysticercosis in Asia.

The Southeast Asian journal of tropical medicine and public health·2003
Same author

Enhanced insulin gene expression by reduced intracellular glutathione level in insulin secreting cells MIN6.

Diabetes, nutrition & metabolism·2003
Same author

Taenia solium taeniasis/cysticercosis in Papua, Indonesia in 2001: detection of human worm carriers.

Journal of helminthology·2003
Same author

Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine: usefulness of ELISA using purified glycoproteins and recombinant antigen.

Veterinary parasitology·2003
Same author

Acute effects of ethanol on feeding behavior and leptin-induced STAT3 phosphorylation in rat hypothalamus.

International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity·2003
Same author

Dogs as alternative intermediate hosts of Taenia solium in Papua (Irian Jaya), Indonesia confirmed by highly specific ELISA and immunoblot using native and recombinant antigens and mitochondrial DNA analysis.

Journal of helminthology·2002
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

High cholesterol levels contribute to atherosclerosis, while high-density lipoprotein (HDL) reduces cardiovascular risk. Endocrine disorders like acromegaly, hypothyroidism, and Cushing syndrome can accelerate atherosclerosis by worsening lipid profiles and other risk factors.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Metabolic Disorders

Context:

  • High cholesterol and low high-density lipoprotein (HDL) levels are linked to atherosclerosis and cardiovascular mortality.
  • Endocrine disorders can significantly accelerate atherosclerosis development.
  • Specific conditions like acromegaly, hypothyroidism, and Cushing syndrome present with dyslipidemia and other cardiovascular risk factors.

Purpose:

  • To explore the intricate relationship between endocrine disorders and the acceleration of atherosclerosis.
  • To elucidate how hormonal imbalances impact lipid metabolism and cardiovascular health.
  • To highlight the role of specific endocrine conditions in exacerbating atherosclerosis through various pathophysiological mechanisms.

Summary:

  • High cholesterol levels are a known risk factor for atherosclerosis, whereas elevated HDL levels are cardioprotective.

Related Experiment Videos

  • Endocrine disorders, including acromegaly, hypothyroidism, and Cushing syndrome, are associated with accelerated atherosclerosis.
  • These conditions often manifest with hypercholesterolemia, hypertension, low HDL, hypertriglyceridemia, and impaired glucose tolerance, collectively promoting cardiovascular disease.
  • Estrogen replacement therapy may offer cardiovascular benefits in postmenopausal women by favorably altering lipid profiles (decreasing LDL, increasing HDL).

    • Impact:

    • Understanding these associations can guide the development of targeted therapeutic strategies for managing cardiovascular risk in patients with endocrine disorders.
    • This knowledge emphasizes the importance of screening for and managing lipid abnormalities and other cardiovascular risk factors in endocrine disease management.
    • Highlights the potential for hormonal modulation to impact cardiovascular outcomes, particularly in postmenopausal women.